R.M. Vos

Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden

Boons, C. C. L. M., den Hartog, Y. M., Janssen, J. J. W. M., Zandvliet, A. S., Vos, R. M., Swart, E. L., Hendrikse, N. H. & Hugtenburg, J. G., 1 Aug 2020, In: European journal of haematology. 105, 2, p. 148-155 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

The natural history of classic galactosemia: Lessons from the GalNet registry

Rubio-Gozalbo, M. E., Haskovic, M., Bosch, A. M., Burnyte, B., Coelho, A. I., Cassiman, D., Couce, M. L., Dawson, C., Demirbas, D., Derks, T., Eyskens, F., Forga, M. T., Grunewald, S., Häberle, J., Hochuli, M., Hubert, A., Huidekoper, H. H., Janeiro, P., Kotzka, J., Knerr, I., & 23 othersLabrune, P., Landau, Y. E., Langendonk, J. G., Möslinger, D., Müller-Wieland, D., Murphy, E., Õunap, K., Ramadza, D., Rivera, I. A., Scholl-Buergi, S., Stepien, K. M., Thijs, A., Tran, C., Vara, R., Visser, G., Vos, R., de Vries, M., Waisbren, S. E., Welsink-Karssies, M. M., Wortmann, S. B., Gautschi, M., Treacy, E. P. & Berry, G. T., 27 Apr 2019, In: Orphanet Journal of Rare Diseases. 14, 1, 86.

Research output: Contribution to journal › Article › Academic › peer-review